| Previous Close | 6.84 |
| Open | 6.84 |
| Bid | 6.76 x 0 |
| Ask | 6.85 x 0 |
| Day's Range | 6.68 - 6.89 |
| 52 Week Range | 5.82 - 13.87 |
| Volume | 512,485 |
| Avg. Volume | 630,857 |
| Market Cap | 2.376B |
| Beta (5Y Monthly) | 1.78 |
| PE Ratio (TTM) | 3.48 |
| EPS (TTM) | 1.95 |
| Earnings Date | Aug. 06, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.41 |
- Motley Fool
Better Marijuana Stock to Buy: Cronos or Canopy Growth?
For a long time, Cronos Group (NASDAQ: CRON) was unable to climb higher than third place among Canadian cannabis producers based on market cap. Meanwhile, Canopy Growth (NYSE: CGC) has fairly consistently held onto the top spot except for brief periods. Neither Cronos nor Canopy has made investors happy so far in 2020, however.
- Motley Fool
Don't Buy Cronos Group Stock Until You See This
Its partnership with tobacco giant Altria is appealing, but keep an eye on these three issues before you pick this pot stock.
- Yahoo Finance Video
State ballot measures to legalize cannabis add $9B to U.S. market: RPT
John Kagia, New Frontier Data Cheif Knowledge Officer, joins Yahoo Finance's Zach Guzman to discuss the cannabis outlook amid COVID-19 and the 2020 Presidential election.
© 2020 Verizon Media. All rights reserved.
